Sort by
Refine Your Search
-
Listed
-
Program
-
Employer
-
Field
-
24 May 2024 Job Information Organisation/Company University College Dublin Research Field Medical sciences » Medicine Researcher Profile First Stage Researcher (R1) Country Ireland Application Deadline 6 Jun 2024 - 01:05 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded...
-
5 Jun 2024 Job Information Organisation/Company University College Dublin Research Field Chemistry » Biochemistry Researcher Profile First Stage Researcher (R1) Country Ireland Application Deadline 2 Jul 2024 - 09:01 (UTC) Type of Contract Temporary Job Status Full-time Is the job funded through...
-
technologies modulate B cell responses in a relevant large animal model of vaccination. This SFI-funded project aims to understand the mechanism of action of two non-injected, thermostable, influenza vaccines
-
industries. The scientist will be based in the School of Biochemistry and Cell Biology and in the School of Pharmacy, UCC. The overall multidisciplinary OptiViVax team provides a global network of clinicians
-
postdoc position supported by Science Foundation Ireland is available for a period of 12 months. Start date will be June 2024 or soon thereafter. As the successful applicant you will develop biocatalysed
-
systems for optimizing T-cell therapies. The project will focus on investigating two types of cancers: liver cancer (HEPG2) and osteosarcoma (SaOS2). The primary objective is to demonstrate, in real-time
-
at the heart of the analysis. The PostDoc will create and develop their own case study for the duration of their post as agreed with the PI. It is envisaged that the case study will concentrate principally
-
degeneration, loss of tissue functionality drives local inflammation, which reduces cell anabolic activity and promotes adoption of pathological catabolic and senescent cell phenotypes. This inflammatory
-
). The candidate will work with Lachnospiraceae strains isolated from healthy individuals to examine their anti-inflammatory potential in intestinal epithelial cell systems including cell lines and organoids (3D
-
Lachnospiraceae strains isolated from healthy individuals to examine their anti-inflammatory potential in intestinal epithelial cell systems including cell lines and organoids (3D mini-guts) and in animal models